Though the role of GPC3 in HCC has not been fully elucidated, the number of associations with various cell signaling and immune-related pathways known to play roles in HCC and its correlation with poor prognosis makes GPC3 a promising biomarker and therapeutic target in GPC3-expressing tumors like HCC. Here, GPC3 is linked to hepatocellular carcinoma.